Codex @codex  0

Acquired immunodeficiency syndrome, commonly AIDS, is the most severe stage of infection with a human immunodeficiency virus. Damage to immune defenses allows serious opportunistic infections and other characteristic illnesses. HIV-1 is a virus; acquired immunodeficiency syndrome is a clinical syndrome associated with advanced disease, not another name for the viral particle or for every positive infection test. Effective antiretroviral treatment can prevent progression to this stage.^[ref]

An early observation was a cluster of unusual infections rather than a direct measurement of a newly identified virus. The CDC's5June1981 report described five young men treated at three Los Angeles hospitals for biopsy-confirmed Pneumocystis pneumonia. The report also described other infections and profoundly reduced in-vitro proliferative responses in the three patients whose lymphocyte function was tested.^[ref]

The denominator matters: three abnormal tests out of three tested patients is not evidence that all five were tested, nor does it estimate the frequency of immune dysfunction in a general population. The pattern motivated investigation of a shared immunodeficiency, while the case series alone did not establish its cause or route of transmission.

The scientific distinction remains useful. An organism that is usually controlled can become pathogenic when host defenses fail; investigating the infection and investigating the underlying immune defect answer different questions. Conversely, a single nonspecific symptom cannot establish acquired immunodeficiency syndrome, and a human immunodeficiency virus infection need not have progressed to that syndrome.

A chemokine receptor is a cell-surface receptor that recognizes a chemokine. Conventional chemokine receptors couple ligand recognition to G protein signaling, often helping leukocytes respond to spatial chemical cues. A chemokine receptor should not be confused with the secreted chemokine that binds it. The wider family includes atypical members whose signaling and ligand-handling properties require separate description.^[ref]

An important experimental example is a receptor being used for a purpose beyond its normal signaling role. H. Deng and colleagues reported that the receptor then called CC-CKR-5, now CCR5, provided a principal entry cofactor for the envelope proteins of primary macrophage-tropic HIV-1 strains. CD4 alone did not account for the entry requirements, and the result differed from the cofactor used by the tested T-cell-line-adapted viruses.^[ref]

This illustrates why binding, signaling and viral entry must be distinguished. A cell might express CD4 yet lack a compatible additional entry factor; conversely, detecting a chemokine receptor does not demonstrate infection. A receptor-expression comparison can therefore test an entry requirement without establishing that every virus strain uses the same receptor. In migration experiments, receptor expression likewise does not by itself measure the direction, speed or persistence of cell movement.

A co-receptor is a receptor that acts with another receptor in a specified recognition, signaling or entry process. The word describes a functional partnership: which partner is needed depends on the biological system and the measured response. It does not mean that every receptor involved must have the same normal ligand or physiological role.

A revealing example is entry by certain HIV-1 isolates. H. Deng and colleagues reported in 1996 that CD4 alone did not explain entry requirements. The chemokine receptor then called CC-CKR-5, now CCR5, supported entry mediated by the envelopes of tested primary macrophage-tropic HIV-1 strains. The comparison with T-cell-line-adapted viruses showed why a co-receptor must be identified in a particular virus–cell context.^[ref]

The conceptual experiment separates recognition from sufficiency: possessing one required cell-surface receptor does not ensure that a cell has all the components needed for entry. Nor does identifying entry cofactors by itself establish every later step of a productive infection.

H. Deng is the first-listed author of a 1996 study identifying CCR5 as a major co-receptor for entry by tested primary HIV-1 isolates. The work addressed a specific puzzle: CD4 was a necessary recognition component, but its presence alone did not explain why different HIV-1 isolates entered different kinds of host cells. The paper showed that the chemokine receptor then called CC-CKR-5, now CCR5, supported entry mediated by the envelopes of primary macrophage-tropic HIV-1 strains.^[ref]

The useful conceptual example is that a host cell can possess CD4 yet lack the additional receptor combination used by a particular HIV-1 isolate. The study contrasted this entry pattern with that of viruses adapted to T-cell lines. It therefore established a receptor contribution for specified virus–cell combinations, rather than a rule that one co-receptor serves every HIV-1 isolate. This distinction connects molecular recognition at the cell membrane with differences in which cells a virus can enter.^[ref]

HIV-1, human immunodeficiency virus type 1, is a human retrovirus in the genus Lentivirus and family Retroviridae. It can cause acquired immunodeficiency syndrome, an advanced stage of HIV infection; the virus and the disease stage are distinct concepts.^[ref]

Its virion has a viral envelope and an internal core containing the RNA genome and replication machinery. During infection, reverse transcription produces a DNA copy, which becomes integrated into host-cell DNA as a provirus. This RNA-to-DNA step is a defining part of retroviral replication.^[ref] The primate lentiviruses use CD4 together with a chemokine receptor for cell recognition and entry.^[ref]

An idealized counting example distinguishes molecular and particle quantities. An orthoretroviral particle packages a dimer of genomic RNA: a preparation containing 100 intact such particles would contain 200 packaged RNA molecules. Counting RNA molecules therefore need not give the same number as counting virions.^[ref]

Actual nucleic-acid measurements can also detect material outside complete particles. Particle assembly, integration and successful infection require different evidence, so the measured object must be specified rather than treating every virus-associated signal as the same biological quantity.

HIV-1 protease is an aspartic protease of HIV-1. It catalyses peptide bond hydrolysis during viral maturation. The active enzyme is a protein dimer made from two identical subunits, each about $11\mathrm{kDa}$. Thus a single isolated subunit and the assembled catalytic enzyme are different molecular objects.^[ref]

Cleavage specificity depends on the amino-acid residues around the bond. In the nomenclature $P_1\mid P_1^{\prime }$, the vertical line marks the cleaved bond: $P_1$ is on one side and $P_1^{\prime }$ on the other. The enzyme favors a hydrophobic $P_1$ residue, while $P_1^{\prime }$ varies and is often proline.^[ref]

A short peptide assay can therefore test cleavage of one specified sequence, but its result is conditional on that substrate and the assay conditions. Measuring disappearance of the uncleaved peptide or appearance of a cleavage product addresses chemical processing directly. It differs from measuring the number of viral particles, which additionally depends on many other steps. The enzyme's role in maturation explains why inhibiting its activity can disrupt that process and why it is an antiviral drug target.^[ref]

HIV-2 is one of the two recognized types of human immunodeficiency virus, alongside HIV-1. Like HIV-1, it is a Lentivirus whose infection can lead to AIDS. These type names identify related viruses; they do not name successive stages of one infection.^[ref][ref]

A landmark 1986 report by F. Clavel and colleagues described a distinct human retrovirus recovered from two patients with AIDS from western Africa. The researchers found biological and morphological similarities to the virus then called LAV/HTLV-III, while some antigens differed. The combination made the classification question experimentally meaningful: similar appearance and disease association did not establish that the agents were identical.^[ref]

The logic can be illustrated with an abstract identification problem. Suppose two virus preparations share an observed structural feature, while one tested antigen differs. The shared observation supplies evidence of similarity; the differing observation supplies a way to distinguish the preparations. Neither one measurement alone establishes all their evolutionary relationships. A scientific classification combines such comparisons with further molecular evidence.

The shared reverse transcription strategy explains the placement of HIV-2 within Retroviridae, whereas distinguishing it from HIV-1 requires information finer than that family-level mechanism. A broad replication category and a type-specific identification answer different biological questions.

Human immunodeficiency virus is the name used for two related retroviruses, HIV-1 and HIV-2, whose infection can lead to AIDS. The virus and the disease stage are distinct: AIDS is the most advanced stage of human immunodeficiency virus infection, rather than the name of every infection.^[ref]

Both belong to Lentivirus, within Orthoretrovirinae and Retroviridae. Their replication connects an RNA genome, a DNA intermediate formed by reverse transcription, and an integrated provirus. In primate lentiviruses, entry involves CD4 and a chemokine receptor; identifying a cell receptor and measuring subsequent virus production are distinct experimental questions.^[ref][ref]

A constructed measurement example distinguishes a molecular quantity from a biological outcome. Suppose an assay reports 100 viral RNA copies in an analysed equivalent of one microlitre of plasma. The corresponding viral load is $100\times 1000=100,000$ RNA copies per millilitre, assuming the assay's stated calibration and volume correction. That count is not a direct count of infectious virions, and it does not by itself specify a person's disease stage. The measured material, normalization and biological question must all be stated.

Lentivirus is a genus within Retroviridae that includes HIV-1 and feline immunodeficiency virus. Members infect several mammalian host groups. Their virions characteristically have an internal core that appears bar-like or cone-shaped in structural observations.^[ref]

The name covers a shared evolutionary grouping rather than one human disease. Primate lentiviruses use CD4 together with a chemokine receptor for recognition and entry; that statement is narrower than claiming that every member of the genus uses the same host receptor.^[ref]

The genus illustrates complementary kinds of evidence. Electron microscopy reveals particle morphology, while genome comparisons examine sequence divergence and distinctive genetic features. The ICTV account describes species demarcation increasingly in terms of genome evidence, alongside historical criteria such as host range and antigenic properties.^[ref]

A cone-shaped core can consequently be an informative structural observation without uniquely identifying a viral species. Conversely, sequence-based placement does not by itself measure the entry properties of a particle in a particular cell. Classification and functional characterization answer connected but different scientific questions.

Retroviridae is a taxonomic family of enveloped viruses whose replication involves reverse transcription and integration of the resulting DNA into host-cell DNA. The integrated form is a provirus, from which host machinery can make viral RNA. Thus the replication cycle links RNA and DNA forms rather than remaining entirely in one nucleic-acid form.^[ref]

A virion contains a viral envelope, an internal core, genomic nucleic acid and replication enzymes. Orthoretrovirinae package a dimer of single-stranded RNA. In Spumaretrovirinae, reverse transcription can already be partly completed in the particle, so a family-wide description should not require every virion to contain only RNA.^[ref]

HIV-1, in the genus Lentivirus, is one member of this broader family. The family name therefore supplies a classification shared by multiple genera, rather than another name for HIV-1 alone.

The RNA-to-DNA-to-RNA cycle also clarifies measurement. A test detecting a proviral DNA sequence addresses a different molecular form from a test detecting packaged RNA. Demonstrating one intermediate can support the proposed replication pathway, but its abundance alone does not count every completed infectious particle. The assay must identify which stage and material it measures.